Stocks / Pharmaceuticals

SNDXPharmaceuticals

Syndax Pharmaceuticals, Inc.
$18.631d -4.9%5d -11.1%settled close · 2026-09-10
Mkt cap $2.1B (9/8)β 0.0852w $16.96–25Shares 88.2MInd. Pharmaceutical PreparationsNasdaq since 2016Emp. 298HQ New York, NYsyndax.com
Who’s talkingIdea Scout · free

Who’s talking about SNDX

No tracked investor commentary on SNDX yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 2 Nov 2026

Confirmed date · consensus EPS -0.43. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where SNDX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 10 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-10
2026-08-26
2026-08-25
2026-08-24
2026-08-21
2026-08-13
2026-08-11
2026-08-06
2026-08-04
2026-07-08
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on SNDX is in this morning’s Brief. Get The Brief — $20/mo →